LVT LTD
Company number 13139796 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
LVT LTD - Analysis Report
Company Number: 13139796
Analysis Date: 2025-07-20 16:26 UTC
Financial Health Assessment of LVT LTD as of 31 January 2024
1. Financial Health Score: D
Explanation:
LVT LTD exhibits signs of financial distress, reflected in significant net liabilities and a deteriorated liquidity position in the latest accounting period. The company's net assets turned sharply negative to -£1,870,000 in 2024 from a neutral or mildly positive position in prior years. This indicates serious solvency issues and a capital structure under strain.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Current Assets | £1,540,000 | Healthy cash and short-term assets, indicating some liquidity resources available. |
| Current Liabilities | £1,870,000 | Very high short-term obligations exceeding current assets, signaling liquidity stress. |
| Net Current Assets | -£330,000 | Negative working capital—symptom of cash flow strain and potential difficulties meeting short-term debts. |
| Total Net Assets | -£1,870,000 | Negative shareholder equity, a critical sign of insolvency risk and capital erosion. |
| Share Capital | £1.00 | Nominal capital base, typical for micro-entities but insufficient to buffer losses. |
| Average Number of Employees | 5 | Slight growth in headcount, indicating operational expansion despite financial challenges. |
3. Diagnosis
LVT LTD is currently in a precarious financial condition. The company shows symptoms of distress such as a significant increase in current liabilities outpacing current assets, resulting in a negative working capital position. The net asset position has deteriorated drastically from a stable or zero equity base in previous years to a large deficit of nearly £1.9 million. Such a negative equity position is akin to a "low blood pressure" warning in a patient—signifying that the company’s financial "vital organs" (capital reserves) are failing to sustain operational demands.
Despite an increase in current assets, primarily cash or receivables, the surge in liabilities suggests either increased borrowing or unpaid obligations, which could threaten the company’s solvency if not addressed promptly. The expanded workforce signals ongoing operations, but this growth must be carefully managed against the cash flow constraints.
The director's report and accounts do not indicate audit requirements, but the financial snapshot strongly suggests the need for close monitoring and potential restructuring.
4. Recommendations
Improve Liquidity Management:
Address the negative working capital by accelerating receivables collection, negotiating extended payment terms with creditors, or liquidating non-essential assets to increase available cash flow.Capital Injection or Restructuring:
Given the large negative net asset position, consider raising additional equity capital or restructuring existing debt to stabilize the balance sheet and reduce insolvency risk.Cost Control and Operational Review:
Evaluate operational expenses, especially given the increase in employees, to ensure staffing and overhead costs align with revenue generation and cash flow realities.Engage Professional Advisory:
Consult restructuring specialists or insolvency advisers to explore options such as formal turnaround plans or informal creditor arrangements before distress worsens.Regular Financial Monitoring:
Implement rigorous monthly financial reviews to track liquidity ratios, debt servicing capacity, and cash flow forecasts to detect early warning signs and act swiftly.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.